EQS-Adhoc: IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05
|
EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word(s): Research Update/Research Update IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05 25-Nov-2021 / 23:10 CET/CEST Release of an ad hoc... |